Novel guidelines for preclinical Alzheimer’s disease

22. March 2016

Our group has participated in a recent effort to formulate novel recommendations about the definitions, the limits, the natural history, the markers of progression, and the ethical consequence of detecting Alzheimer’s disease at its preclinical, asymptomatic stage. This work is the result of a workshop held by the International Working Group (IWG) and the American Alzheimer’s Association on “The Preclinical State of AD” on July 23, 2015; Washington DC, USA. The guidelines were recently published in the journal Alzheimer’s & Dementia.